The Cleveland Clinic joins the PATHFINDER study, a multi-center effort that is evaluating the implementation of an investigational multi-cancer early detection blood test in clinical practice. The OHSU Knight Cancer Institute is among the six sites across the country participating.

Fay Horak, Ph.D., P.T., says a shuffling gait is caused by imbalance and slow movement in Parkinson’s patients and can be reduced with dopamine replacement therapy.

Eric Fombonne, M.D., says a study that found 0.7% of children in China have autism is “is a very strong starting point” to better understand how common the condition is in China.

Multiple sclerosis researchers at OHSU are among those involved in the Centers Without Walls collaborative program, which will be supported by the Sept. 4 Erase MS Gala in Pasadena, California.

A 63-year-old Eugene man is enjoying life two months after receiving a donated heart. John Masson says OHSU staff have been “as involved and invested in my heart transplant as I am.”

Kyle Johnson, M.D., and Eliza Hayes Bakken, M.D., join area educators for a Town Hall to address parents’ questions about the physical and mental impacts of returning to school amidst the pandemic.

Judith Guzman-Cottrill, M.D., says opening school bus windows and establishing a stable group of students can limit the coronavirus’ spread and prevent schools from having to close again during to the pandemic.

Shawn Chavez, Ph.D., comments on the science of fertility and miscarriage. She says: “Up to 80 percent of embryos made through in-vitro fertilization contain at least one chromosomally abnormal cell, and this figure is probably similar for naturally conceived embryos.”

An injured fisherman rescued in Yaquina Bay by the Coast guard was transferred to OHSU for care.

Jacqueline Vuky, M.D., leads new research study finding pembrolizumab yielded meaningful benefit for patients with advanced urothelial cancers, or cancer that begin in urothelial cells that line the urethra, bladder, ureters, renal pelvis, and other organs.